阿普塔默的治疗应用
George Santarpia1, Eric Carnes1
1College of Public Health, University of Nebraska Medical Center, Omaha, NE 68198, USA.
International journal of molecular sciences
|June 27, 2024
概括
亚胺或基于核酸的亲和反应剂,为分子生物学和医学提供了抗体的经济有效替代品. 尽管存在诸如体内稳定性等挑战,但aptamers在FDA批准的药物和新应用程序的持续开发中显示出治疗前景.
科学领域:
- 生物化学 生化学
- 分子生物学分子生物学
- 医学科学 医学科学 医学科学
背景情况:
- 亲和试剂,如抗体,是分子生物学和医学中必不可少的工具.
- 抗体有局限性,包括复杂的生产和成本.
- 阿普塔默是一种可行的替代品,具有独特的优势.
研究的目的:
- 为了突出显示aptamers作为一种多功能类型的亲和反应剂.
- 为了比较aptamers与抗体的优缺点.
- 讨论aptamer的治疗潜力和正在进行的开发.
主要方法:
- 为特定目标结合选择单链DNA或RNA体.
- 在试验室中生产和修改核酸体.
- 审查临床试验数据和FDA批准的基于aptamer的治疗方法.
主要成果:
- 阿普塔默可以结合到各种各样的点,包括那些抗体亲和力较低的点.
- 有成本效益高,无细胞的生产方法可用于aptamer.
- 阿普塔默在临床试验中取得了成功,并获得了FDA治疗用途的批准.
结论:
- 由于其多功能结合能力和成本效益高的生产,aptamers为抗体提供了一个有希望的替代品.
- 正在进行的aptamer开发研究可能会导致新的治疗方法,包括抗毒素和通过组合方法提高疗效.
- 需要进一步开发以应对诸如体内稳定性等更广泛的治疗应用的挑战.
相关概念视频
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
Transducer Mechanism: Enzyme-Linked Receptors
2.4K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
2.4K
Targets for Drug Action: Overview
6.2K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
6.2K


